Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
SAN CARLOS, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the..
SAN CARLOS, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the..
A few days ago, we covered an emerging story out of Washington that the Biden Administration was considering a rewrite of Title IX..
Last night, Prime Minister Benjamin Netanyahu and Israel reportedly retaliated against Iran’s unprecedented attack. According to..